Ivan Foeldvari Selected Research

Ivan Foeldvari Research Topics

Disease

39	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2022 - 05/2002
9	Arthritis (Polyarthritis) 03/2022 - 01/2014
8	Uveitis 01/2022 - 02/2005
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2011
4	Neoplasms (Cancer) 10/2020 - 01/2011
3	Infections 04/2021 - 01/2020
3	Psoriatic Arthritis 01/2019 - 06/2014
3	Body Weight (Weight, Body) 12/2017 - 02/2005
2	Pain (Aches) 01/2022 - 08/2010
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 05/2007
2	Cytopenia 01/2020 - 01/2020
2	Localized Scleroderma (Morphea) 12/2018 - 07/2011
2	Pulmonary Arterial Hypertension 11/2011 - 11/2010
2	Dyspnea (Shortness of Breath) 10/2009 - 06/2008
2	Rheumatic Diseases (Rheumatism) 01/2008 - 05/2002
2	Pulmonary Hypertension 05/2007 - 11/2002
1	Opportunistic Infections (Opportunistic Infection) 04/2021
1	Necrosis 04/2021
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Cutaneous Lupus Erythematosus 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	Herpes Zoster 10/2020
1	Familial Mediterranean Fever (Periodic Disease) 10/2020
1	Macrophage Activation Syndrome 01/2020
1	Cardiomyopathies (Cardiomyopathy) 11/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2019
1	Fibrosis (Cirrhosis) 11/2019
1	Heart Failure 11/2019
1	Amblyopia (Lazy Eye) 07/2019
1	Limited Scleroderma 12/2018
1	Erythema 12/2018
1	Fever (Fevers) 01/2018
1	Injection Site Reaction 01/2018
1	Back Pain (Backache) 01/2017
1	Serositis 01/2017
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2016
1	Drug-Related Side Effects and Adverse Reactions 11/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2014
1	Vasculitis (Vasculitides) 01/2014
1	Ankylosing Spondylitis 10/2012
1	Lymphoma (Lymphomas) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2010
1	Inflammation (Inflammations) 04/2010

Drug/Important Bio-Agent (IBA)

13	Etanercept (Enbrel)FDA Link 01/2021 - 05/2007
11	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 02/2005
8	Biological ProductsIBA 01/2021 - 01/2014
6	Antirheumatic Agents (DMARD)IBA 01/2021 - 06/2010
6	Adalimumab (Humira)FDA Link 10/2020 - 08/2008
4	Abatacept (Orencia)FDA Link 04/2021 - 06/2010
3	Interleukin-1 (Interleukin 1)IBA 04/2021 - 11/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 01/2014
3	C-Reactive ProteinIBA 10/2020 - 01/2018
3	tocilizumab (atlizumab)FDA Link 01/2020 - 11/2017
3	Tumor Necrosis Factor InhibitorsIBA 11/2015 - 01/2011
3	Infliximab (Remicade)FDA Link 01/2011 - 05/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 05/2007
3	Meloxicam (Mobic)FDA LinkGeneric 02/2005 - 05/2002
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2020
2	canakinumab FDA Link 10/2020 - 01/2020
2	SolutionsIBA 07/2019 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 10/2009
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2009 - 02/2005
2	Endothelin Receptor AntagonistsIBA 05/2007 - 11/2002
2	SuspensionsIBA 02/2005 - 08/2004
1	secukinumabIBA 03/2022
1	Carbon MonoxideIBA 01/2022
1	N-phthaloylglutamic acidIBA 01/2022
1	InterleukinsIBA 04/2021
1	Interleukin-6 InhibitorsIBA 04/2021
1	Colchicine FDA LinkGeneric 10/2020
1	SteroidsIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Vasodilator Agents (Vasodilators)IBA 11/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Synthetic DrugsIBA 12/2018
1	Ficusin (Psoralen)IBA 12/2018
1	Prostaglandins AIBA 12/2018
1	GlucocorticoidsIBA 01/2018
1	golimumab FDA Link 01/2018
1	tofacitinibIBA 12/2017
1	TabletsIBA 12/2017
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2017
1	AntibodiesIBA 09/2016
1	Antinuclear AntibodiesIBA 11/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2014
1	ametantrone (HAQ)IBA 11/2011
1	AutoantibodiesIBA 01/2011
1	Dihydrotachysterol (AT 10)IBA 11/2010
1	Leflunomide (Arava)FDA LinkGeneric 08/2010

Therapy/Procedure

15	Therapeutics 03/2022 - 02/2005
3	Biological Therapy 01/2020 - 09/2018
2	Activities of Daily Living (ADL) 10/2009 - 06/2008
1	Premedication 04/2021
1	Phototherapy (Light Therapy) 12/2018
1	Injections 01/2018